← Back to Search

Behavioural Intervention

ePRO Symptom Monitoring for Thoracic Surgery Patients

N/A
Recruiting
Led By Gita Mody, MD, MPH
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be 18 years or older
Patients must be English or Spanish speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 4 through 6 after implementation of the study
Awards & highlights

Study Summary

This trial studied the outcomes of using ePRO monitoring in thoracic surgery patients to track symptoms/functioning & alert providers when something is concerning.

Who is the study for?
This trial is for adults who've had or will have major thoracic surgery, can complete surveys in English or Spanish, and are not pregnant. Excluded are those with minor surgeries, mental conditions affecting consent, prisoners, or if the surgery didn't happen within 3 months after consent.Check my eligibility
What is being tested?
The study tests a health tech intervention called ePRO monitoring. It involves patients reporting their symptoms and physical functioning through electronic surveys post-thoracic surgery, which then automatically alert providers to any concerning responses.See study design
What are the potential side effects?
Since this trial focuses on symptom monitoring rather than medication or invasive procedures, traditional side effects aren't expected. However, there may be privacy concerns regarding personal health data management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I speak English or Spanish.
Select...
I am planning to have or have had major chest surgery within the last 30 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 4 through 6 after implementation of the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 4 through 6 after implementation of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adoption of ePRO monitoring
Reach of ePRO monitoring
Secondary outcome measures
Complication Rate
Emergency department visit at 30 days
Emergency department visit at 90 days
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ePRO monitoringExperimental Treatment1 Intervention
Thoracic surgery patients will be enrolled in ePRO monitoring using web-based or telephone surveys.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,133 Total Patients Enrolled
1 Trials studying Thoracic
91 Patients Enrolled for Thoracic
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,840 Previous Clinical Trials
47,851,924 Total Patients Enrolled
Gita Mody, MD, MPHPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
2 Previous Clinical Trials
154 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study offer enrollment to those aged 25 and above?

"This trial is enrolling patients aged 18 and younger than 99 years old."

Answered by AI

Do I meet the criteria to participate in this trial?

"To take part in this medical trial, candidates must fall between 18 and 99 years old. Additionally, they should have thoracic cancer. As of now, around 200 individuals are expected to join the study."

Answered by AI

What goals does this clinical experiment aim to accomplish?

"The primary aim of this trial in the 4-6 month time frame is to gauge participants' adoption of ePRO monitoring. Secondary targets include assessing the percentage of patients that visit an emergency room during a 30 or 90 day period and also determining how many individuals were readmitted into hospital care at the end of their first month."

Answered by AI

Are there still vacancies available to partake in this research endeavor?

"Evidently, the clinical trial is no longer seeking enrolment as indicated on clinicaltrials.gov - this particular study was initially posted on October 15th 2023 and last edited 3 weeks later. Despite that, there are currently 59 other trials actively recruiting participants."

Answered by AI
~133 spots leftby May 2025